These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 490860)

  • 1. Chemoimmunotherapy for meningeal melanocytoma of the thoracic spinal cord. Report of a case.
    Verma DS; Spitzer G; Legha S; McCredie KB
    JAMA; 1979 Nov; 242(22):2435-6. PubMed ID: 490860
    [No Abstract]   [Full Text] [Related]  

  • 2. DTIC and actinomycin D with and without C. parvum immunotherapy in advanced malignant melanoma.
    Halpern J; Catane R; Biran S; Fuks Z
    Tumori; 1981; 67(3):215-7. PubMed ID: 7281240
    [No Abstract]   [Full Text] [Related]  

  • 3. Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report.
    Salmaggi A; Silvani A; Eoli M; Lamperti E; Boiardi A
    Neurol Sci; 2002 Dec; 23(5):257-8. PubMed ID: 12528690
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma.
    Karakousis CP; Didolkar MS; Han T
    Cancer Treat Rep; 1981; 65(9-10):925-6. PubMed ID: 7273032
    [No Abstract]   [Full Text] [Related]  

  • 5. Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.
    Robidoux A; Gutterman JU; Bodey GP; Hersh EM
    Cancer; 1982 Jun; 49(11):2246-51. PubMed ID: 7042068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma.
    Karakousis CP; Didolkar MS; Lopez R; Baffi R; Moore R; Holyoke ED
    Cancer Treat Rep; 1979; 63(11-12):1739-43. PubMed ID: 393377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.
    Ramseur WL; Richards F; Muss HB; Rhyne L; Cooper MR; White DR; Stuart JJ; Spurr CL
    Cancer Treat Rep; 1978 Jul; 62(7):1085-7. PubMed ID: 356970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningeal melanocytoma with invasion of the thoracic spinal cord. Case report.
    Steinberg JM; Gillespie JJ; MacKay B; Benjamin RS; Leavens ME
    J Neurosurg; 1978 May; 48(5):818-24. PubMed ID: 641559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningeal melanocytoma or multiple pigmented meningioma of the spinal canal. Report of a case. Review of the literature].
    Crouzet J; Richard S; Pillet G; Muckensturm B; Srour A; Pradat P
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):738-43. PubMed ID: 1306593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation of spinal meningeal melanocytoma. Case report and review of the literature.
    Wang F; Li X; Chen L; Pu X
    J Neurosurg Spine; 2007 May; 6(5):451-4. PubMed ID: 17542513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
    Jacquillat C; Banzet P; Civatte J; Puissant A; Cottenot F; Israel L; Belaich S; Chastang C; Maral J
    Recent Results Cancer Res; 1978; 68():346-58. PubMed ID: 111323
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intramedullary meningeal melanocytoma].
    Barth A; Pizzolato GP; Berney J
    Neurochirurgie; 1993; 39(3):188-94. PubMed ID: 8295652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab as adjuvant treatment for a spinal melanocytoma: A case report.
    Hean V; Bouleftour W; Ramirez C; Forest F; Boutet C; Rivoirard R
    Medicine (Baltimore); 2021 May; 100(19):e25862. PubMed ID: 34106633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival.
    Amer MH; Al-Sarraf M; Baker LH; Vaitkevicius VK
    Cancer; 1978 Aug; 42(2):660-8. PubMed ID: 679158
    [No Abstract]   [Full Text] [Related]  

  • 16. Multifocal meningeal melanocytoma: a new pathological entity or the result of leptomeningeal seeding?
    Ali Y; Rahme R; Moussa R; Abadjian G; Menassa-Moussa L; Samaha E
    J Neurosurg; 2009 Sep; 111(3):488-91. PubMed ID: 19361258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal meningeal melanocytoma. Report of two cases and review of the literature.
    Turhan T; Oner K; Yurtseven T; Akalin T; Ovul I
    J Neurosurg; 2004 Mar; 100(3 Suppl Spine):287-90. PubMed ID: 15029918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary intramedullary melanoma. Apropos of a case].
    Magni C; Yapo P; Mocaer J; Renjard L; Sonier CB; Cottier JP; Jan M; Laffont J
    J Neuroradiol; 1996 Jun; 23(1):41-5. PubMed ID: 8767918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ineffectiveness of adjuvant chemotherapy using DTIC and cyclophosphamide in patients with resectable metastatic melanoma.
    Balch CM; Murray D; Presant C; Bartolucci AA
    Surgery; 1984 Apr; 95(4):454-9. PubMed ID: 6369594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary dural melanomas: report of two cases and review of the literature.
    Ozden B; Barlas O; Hacihanefioğlu U
    Neurosurgery; 1984 Jul; 15(1):104-7. PubMed ID: 6472585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.